Not medical advice. Talk to your provider before using any peptide.
Full disclaimerSemaglutide at 0.025-0.05mg weekly, roughly 1/10th the standard starting dose. Dr. Tyna Moore's philosophy: "Dose up to appetite control, not suppression." Exact microgram dose is not publicly verified; the approach and philosophy come from multiple interviews including Ben Greenfield Life. She treats GLP-1 as scaffolding for building metabolic habits, not a permanent prescription.
Most lose 2–5 lbs (largely water and reduced intake). Some notice nothing. A minority gets significant nausea from week one. The notable early change is psychological: food thoughts become less intrusive.
"Food noise" noticeably quiets. Eating half-portions without effort is common. Weight loss picks up to 1–2 lbs/week. Nausea peaks in the first 2–3 days at each new dose increase, then fades. Constipation typically begins here.
The community "sweet spot." Strong appetite suppression and consistent scale movement. Physical changes visible around week 12. Energy improves. Unexpected and widely reported: reduced alcohol tolerance and cravings. Some users stay at 1.0 or 1.7 mg rather than escalating: sufficient appetite control with fewer side effects.
For educational purposes only. Not medical advice. Consult a healthcare provider before starting any peptide protocol.
